BCHE and Alzheimer disease: In addition, treatments for AD primarily focus on alleviating symptoms and slowing disease progression, with existing therapies mainly utilizing cholinesterase inhibitors and NMDA (N-Methyl-D-aspartate) receptor antagonists [37].